Literature DB >> 22203334

Sural nerve pathology in ALS patients: a single-centre experience.

Marco Luigetti1, Amelia Conte, Alessandra Del Grande, Giulia Bisogni, Angela Romano, Mario Sabatelli.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive degenerative disease of upper and lower motor neurons. Sensory involvement is thought not to be a feature of ALS. We reviewed 17 cases of sural nerve biopsies performed in a large cohort of ALS patients referred to our centre over a 23-year period. More than two-third of biopsies revealed a variable degree of axonal loss. In one case, pathological findings suggested the concomitant presence of an inherited neuropathy, subsequently confirmed by genetic evaluation. In another case, pathological and neurographic data were similar to those of an inflammatory demyelinating neuropathy, but the clinical course corroborated the diagnosis of ALS. Our data confirm that sensory nerve involvement may be found in ALS patients. This finding should prompt physicians to carefully investigate a possible alternative diagnosis, but does not exclude the possibility that the patient may have ALS.

Entities:  

Mesh:

Year:  2011        PMID: 22203334     DOI: 10.1007/s10072-011-0909-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  19 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies.

Authors:  Claudia L Sommer; Sebastian Brandner; Peter J Dyck; Yadollah Harati; Catherine LaCroix; Martin Lammens; Laurent Magy; Svein I Mellgren; Michela Morbin; Carmen Navarro; Henry C Powell; Angelo E Schenone; Ersin Tan; Andoni Urtizberea; Joachim Weis
Journal:  J Peripher Nerv Syst       Date:  2010-09       Impact factor: 3.494

3.  Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary.

Authors:  Michael P Collins; P James B Dyck; Gary S Gronseth; Loïc Guillevin; Robert D M Hadden; Dieter Heuss; Jean-Marc Léger; N C Notermans; John D Pollard; Gérard Said; Gen Sobue; A F J E Vrancken; John T Kissel
Journal:  J Peripher Nerv Syst       Date:  2010-09       Impact factor: 3.494

4.  Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS.

Authors:  Mario Sabatelli; Marcella Zollino; Marco Luigetti; Alessandra Del Grande; Serena Lattante; Giuseppe Marangi; Mauro Lo Monaco; Francesca Madia; Emiliana Meleo; Giulia Bisogni; Amelia Conte
Journal:  Amyotroph Lateral Scler       Date:  2011-07

5.  Small-fiber neuropathy in patients with ALS.

Authors:  J Weis; I Katona; G Müller-Newen; C Sommer; G Necula; C Hendrich; A C Ludolph; A-D Sperfeld
Journal:  Neurology       Date:  2011-06-07       Impact factor: 9.910

6.  Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment.

Authors:  Grazia Devigili; Nurcan Uçeyler; Marcus Beck; Karlheinz Reiners; Guido Stoll; Klaus V Toyka; Claudia Sommer
Journal:  Acta Neuropathol       Date:  2011-05-28       Impact factor: 17.088

7.  Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion.

Authors:  J Desai; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

8.  Chronic inflammatory demyelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis.

Authors:  Yusuf A Rajabally; Saiju Jacob
Journal:  Muscle Nerve       Date:  2008-07       Impact factor: 3.217

9.  Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

Authors:  L J Haverkamp; V Appel; S H Appel
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

10.  Sensory and motor neuronopathy in a patient with the A382P TDP-43 mutation.

Authors:  Jean-Philippe Camdessanché; Véronique V Belzil; Guillemette Jousserand; Guy A Rouleau; Christelle Créac'h; Philippe Convers; Jean-Christophe Antoine
Journal:  Orphanet J Rare Dis       Date:  2011-02-05       Impact factor: 4.123

View more
  7 in total

Review 1.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

2.  Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?

Authors:  Nadja Borisow; Thomas Meyer; Friedemann Paul
Journal:  BMJ Case Rep       Date:  2013-01-23

3.  Analysis of clinical and electrophysiological characteristics of 150 patients with amyotrophic lateral sclerosis in China.

Authors:  Jie Liu; Xuehua Zhang; Xiaojun Ding; Min Song; Kexu Sui
Journal:  Neurol Sci       Date:  2018-11-23       Impact factor: 3.307

4.  Impaired pain processing and its association with attention disturbance in patients with amyotrophic lateral sclerosis.

Authors:  Yumiko Harada; Tomohiko Nakamura; Masashi Suzuki; Masamichi Ueda; Masaaki Hirayama; Masahisa Katsuno
Journal:  Neurol Sci       Date:  2021-01-04       Impact factor: 3.307

5.  CMAP decrement by low-frequency repetitive nerve stimulation in different hand muscles of ALS patients.

Authors:  Dong Zhang; Yuying Zhao; Chuanzhu Yan; Lili Cao; Wei Li
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

6.  Visualization of Sensory Neurons and Their Projections in an Upper Motor Neuron Reporter Line.

Authors:  Barış Genç; Amiko Krisa Bunag Lagrimas; Pınar Kuru; Robert Hess; Michael William Tu; Daniela Maria Menichella; Richard J Miller; Amy S Paller; P Hande Özdinler
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

7.  Increased axonal ribosome numbers is an early event in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  Mark H G Verheijen; Marco Peviani; Rita Hendricusdottir; Erin M Bell; Martin Lammens; August B Smit; Caterina Bendotti; Jan van Minnen
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.